Revolution Medicines Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Revolution Medicines, Inc. (RVMD) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents0.540.700.640.110.44
Short-Term Investments1.751.160.480.470.34
Cash & Short-Term Investments2.291.850.640.580.44
Accounts Receivable0.000.000.000.010.01
Inventory0.000.000.000.000.00
Other Current Assets0.040.030.010.010.00
Total Current Assets2.331.880.660.590.45
Non-Current Assets
Property, Plant & Equipment (Net)0.140.100.070.070.04
Goodwill0.010.010.010.010.01
Intangible Assets0.060.060.060.060.06
Other Non-Current Assets0.020.010.000.000.00
Total Non-Current Assets0.230.180.150.150.11
Total Assets2.562.060.810.740.57
Current Liabilities
Accounts Payable0.050.060.020.010.01
Short-Term Debt0.010.000.000.000.00
Accrued Liabilities0.100.070.020.020.02
Deferred Revenue0.000.000.000.010.01
Other Current Liabilities0.000.000.030.000.02
Total Current Liabilities0.160.140.060.060.05
Non-Current Liabilities
Long-Term Debt0.120.080.060.060.03
Deferred Tax Liabilities0.000.000.010.010.01
Other Non-Current Liabilities0.000.010.000.000.00
Total Non-Current Liabilities0.130.090.060.080.05
Total Liabilities0.290.240.130.140.09
Stockholders' Equity
Common Stock0.000.000.000.000.00
Retained Earnings-1.74-1.14-0.70-0.45-0.27
Accumulated Other Comprehensive Income0.000.000.000.000.00
Additional Paid-in Capital4.002.961.391.060.74
Shares Outstanding0.190.160.090.070.00
Total Stockholders' Equity2.271.830.690.600.47
Total Liabilities & Equity2.562.060.810.740.57